Licensing and supply agreement for JUXTAPIDJuly 4th, 2024FiledJuly 4th, 2024Aegerion Pharmaceuticals has entered into an exclusive licensing agreement with Recordati Rare Diseases for the commercialization of JUXTAPID (lomitapide) in Japan.
Aegerion Pharmaceuticals has entered into an exclusive licensing agreement with Recordati Rare Diseases for the commercialization of JUXTAPID (lomitapide) in Japan.